Previously Untreated CLL/SLL

DESIGNED TO BE DIFFERENT.
DESIGNED TO BE COMPLETED IN 12 MONTHS.

Actor portrayal.

VENCLEXTA + GAZYVA® (obinutuzumab) is a chemo-free, oral-based treatment designed to be completed in 12 months.

What can treatment completion with VENCLEXTA + GAZYVA mean for you?

Time Icon

Fixed treatment period

VENCLEXTA + GAZYVA is designed to be completed in 12 months. After completion, you may look forward to a treatment-free period.

Calculator Icon

Fixed cost

Because treatment with VENCLEXTA is completed in a set amount of time, your out-of-pocket costs for a VENCLEXTA-based regimen are limited to 12 months for previously untreated patients.* Learn more about financial and treatment support.

*Coverage may vary by health plan. You may still incur out-of-pocket costs for other treatments or tests as directed by your healthcare provider.

Clock icon

Fixed amount of drug exposure

A VENCLEXTA-based regimen is taken for a fixed period of time—there is no additional VENCLEXTA exposure after completing treatment.

  

PATIENT STORY

“It really appealed to me. With VENCLEXTA, there’s an end date to treatment.”

Ask your doctor about VENCLEXTA

Download a list of helpful questions to get the conversation started.

Graph icon

Established efficacy and safety

Learn more about results from the VENCLEXTA clinical trial.

PATIENT BROCHURE

Get more information about treatment with VENCLEXTA

FOLLETO PARA PACIENTES

Obtener más información sobre el tratamiento con VENCLEXTA

Actor portrayal.

Learn more about how VENCLEXTA can help